Search clinical trials for: Recombinant Activated Protein C
Total 921 results
-
University of British ColumbiaCompleted
-
University of VersaillesAssistance Publique - Hôpitaux de Paris; Ministry of Health, FranceCompleted
-
University of Roma La SapienzaCompletedSepsis | Septic ShockItaly
-
Helsinki University Central HospitalCompleted
-
Novo Nordisk A/SWithdrawnHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B
-
Novo Nordisk A/SCompletedSpinal Fusion | Acquired Bleeding DisorderUnited States
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageJapan
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Glanzmann's DiseaseJapan
-
Universiti Sains MalaysiaCompletedMassive Hemorrhage | Massive Blood Loss | Massive Blood Transfusion; ThrombocytopeniaMalaysia
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderUnited States, Canada
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Acquired Bleeding Disorder | Acquired Haemophilia | Congenital FVII Deficiency | Glanzmann's DiseaseFrance
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageSpain, Sweden, Singapore, Norway, Italy, Switzerland, Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Netherlands, United Kingdom
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding DisorderUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BFrance, Israel, Germany
-
University of CincinnatiNational Institute of Neurological Disorders and Stroke (NINDS)CompletedIntracerebral HemorrhageUnited States, Canada
-
Novo Nordisk A/SCompletedCirrhosis | Acquired Bleeding DisorderGermany, United Kingdom, Spain, Taiwan, France, Italy, Austria, Czech Republic, Poland, Denmark, Finland, Hong Kong
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderIndia, Spain, Canada, Finland, Germany, Israel, Italy, Netherlands, Singapore, Switzerland, Taiwan
-
Novo Nordisk A/SWithdrawnTrauma | Acquired Bleeding DisorderUnited States
-
Novo Nordisk A/SCompletedOther Haemostasis Disorder | Haemorrhagic CystitisUnited States
-
Novo Nordisk A/STerminatedAcquired Bleeding Disorder | Cardiac Surgery Requiring Cardiopulmonary BypassUnited States, Spain, Germany, Sweden, United Kingdom, Argentina, Italy, Brazil, Denmark, France, India, Malaysia, Singapore, South Africa
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United Kingdom, Spain, Israel, Poland, Turkey, Hungary
-
Novo Nordisk A/SCompletedObservational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII DeficiencyCongenital Bleeding Disorder | Congenital FVII DeficiencyJapan
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Acquired Bleeding Disorder | Acquired Haemophilia | Congenital FVII Deficiency | Glanzmann's DiseaseGermany
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageFinland, Singapore, Australia, Spain, Denmark, Germany, Italy, Taiwan, United Kingdom
-
Washington University School of MedicineMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsCompletedVenous Thrombosis | Deep Vein Thrombosis | Postphlebitic Syndrome | Venous Thromboembolism | Post Thrombotic SyndromeUnited States
-
M.D. Anderson Cancer CenterSuspendedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
ApcinteX LtdCentessa Pharmaceuticals plcRecruitingHemophilia B | Hemophilia B With InhibitorUnited States, Spain, Australia, Taiwan, France, Armenia, Germany
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageUnited States
-
Novo Nordisk A/SCompletedTrauma | Acquired Bleeding DisorderGermany, Austria, Israel, France, Canada, Singapore, South Africa, Australia, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSaudi Arabia, Algeria, Turkey, Germany, Poland, Netherlands, Italy, Belgium, South Africa, United Kingdom, Sweden, Austria, Portugal, France, Czech Republic, Venezuela
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSlovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
-
ApcinteX LtdCentessa Pharmaceuticals plcRecruitingHemophilia A | Hemophilia BUnited States, Italy, Spain, Taiwan, Australia, Belgium, United Kingdom, France, Germany, India, South Africa, Canada, Poland, Armenia, Turkey
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsUnited States, Denmark, France, United Kingdom
-
George Washington UniversityEli Lilly and CompanyCompletedEnd Stage Renal DiseaseUnited States
-
Novo Nordisk A/STerminatedAcquired Bleeding Disorder | Bleeding During/Following SurgeryUnited States
-
Novo Nordisk A/SCompletedHealthy | Congenital Bleeding Disorder | Haemophilia A | Haemophilia BUnited Kingdom
-
Joseph Broderick, MDNovo Nordisk A/S; National Institute of Neurological Disorders and Stroke (NINDS)RecruitingIntracerebral HemorrhageUnited States, Canada, Germany, Japan, Spain, United Kingdom
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Bleeding During/Following SurgeryIsrael, Sweden, United Kingdom, Germany, Switzerland, France, Spain, Italy, Thailand, Denmark, United States, Poland, Finland, Singapore, Australia, Austria
-
ZZ Biotech, LLCNational Institute of Neurological Disorders and Stroke (NINDS); University... and other collaboratorsNot yet recruiting
-
ZZ Biotech, LLCMassachusetts General Hospital; National Institute of Neurological Disorders... and other collaboratorsCompleted
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BUnited Kingdom
-
Livzon Pharmaceutical Group Inc.Active, not recruiting
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BSpain, Italy, Greece, Germany, United Kingdom
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Glanzmann's DiseaseSpain, Bulgaria, Pakistan, Belgium, Germany, France, United Kingdom, Italy, Hungary, Netherlands, United States, Algeria, Austria, Sweden, Switzerland
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BMorocco, United Arab Emirates, Algeria, Oman, Saudi Arabia
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI); Genentech, Inc.; RTI International and other collaboratorsWithdrawnVenous Thrombosis | Deep Vein Thrombosis | Post-Thrombotic Syndrome
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsFrance, United States, Spain, Brazil, Philippines, South Africa, Poland, Turkey, Romania, Bulgaria, Russian Federation, Argentina
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A | Haemophilia BBelgium, Germany, France, United Kingdom, Italy, Hungary, Austria, Sweden, Iran, Islamic Republic of, Argentina, Ireland, Poland, Portugal, Slovakia